Point-of-Care and Laboratory Testing Products
Our products apply cutting-edge technology to achieve the same accurate and reliable results you expect from a large laboratory while offering distinct advantages. Patients get immediate results wherever they may be – at home, in the field, or a healthcare provider’s office – and practitioners are empowered to make swift clinical decisions and expedite treatment. For diseases where early detection improves the prognosis for survival, point-of-care testing can be lifesaving, particularly for people in remote areas without access to specialized testing equipment.
Recent global outbreaks of new diseases has caused BioMedomics to seek novel diagnostic tests to help identify and track them easily and accurately. We are working quickly to provide the tools needed by clinicians, epidemiologists, government agencies, and health care providers to fight the spread of infectious diseases.
COVID-19 IgM/IgG Rapid Test
In response to the recent outbreak of novel coronavirus in Wuhan, China, BioMedomics has developed a lateral flow combined antibody (IgM and IgG) rapid test for coronavirus. Detection of COVID-19 IgM antibodies tends to indicate a recent exposure to COVID-19 and detection of COVID-19 IgG antibodies indicates a later stage of infection. The test can provide accurate results in 15 minutes using whole blood, serum, or plasma.
BioMedomics is dedicated to developing point-of-care products that aid in the diagnosis of blood disorders. We give special attention to underserved patient populations and diseases where current diagnostic methods are quite costly and impractical for many communities around the world.
Sickle SCAN ®
BioMedomics Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay used for the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples.
BioMedomics wants to use advances in chemistry and technology to improve current methods of microscopic analysis and make the identification of microorganisms simpler, easier, faster, and more accurate. Here again, our focus is on microorganisms and pathogens of global concern and our solutions consider communities and environments impacted the most by these diseases.
Fungi SCAN™ All-In-One Stain
BioMedomics Fungi SCAN™ All-in-One Stain is a unique sample processing reagent that uses potassium hydroxide (KOH) to dissolve non-fungal cells, a fluorescent compound that binds to ß-polysaccharides in the fungal cell wall, and a counterstain to improve contrast.
BioMedomics is focused on diagnostic tools and technologies that help make women’s lives better by making the diagnosis of diseases specific to women easier, faster, and more reliable. From cellular staining agents to antibody-based tests, we are applying our expertise to developing and commercializing these kinds of products.
Femi SCAN Dual-Fluorescence Stain
BioMedomics Femi SCAN™ is more accurate, easier, and faster than standard wet film smear or gram stain microscopy. Our dual fluorescent staining agent is designed to stain the DNA and RNA of cells and microorganisms in vaginal secretion samples, which then display different colors under fluorescent microscopes. In addition, a fully-automated slide staining system is available to ensure consistency and make slide preparation fast and simple.